400 Investigation of a translational astrocyte-targeted AAV-mediated gene addition therapy in two models of Vanishing White Matter disease
OBJECTIVES/GOALS: Vanishing White Matter Disease (VWM), is a childhood neurodegenerative leukodystrophy that presents with motor deficits, neurologic decline, and seizures leading to death.There are no treatments. Herein we investigate adeno-associated virus serotype 9 (AAV9) gene addition therapy f...
Main Authors: | Jessica A. Herstine, Pi-Kai Chang, Sergiy Chornyy, Tamara J. Stevenson, Jessica Rediger, Julia Wentz, Nettie Pyne, Joshua L. Bonkowsky, Allison M. Bradbury |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2024-04-01
|
Series: | Journal of Clinical and Translational Science |
Online Access: | https://www.cambridge.org/core/product/identifier/S2059866124003480/type/journal_article |
Similar Items
-
Lithium: effects in animal models of vanishing white matter are not promising
by: Diede Witkamp, et al.
Published: (2024-01-01) -
Vanishing white matter disease expression of truncated EIF2B5 activates induced stress response
by: Matthew D Keefe, et al.
Published: (2020-12-01) -
Proteomic and Metabolomic Analyses of Vanishing White Matter Mouse Astrocytes Reveal Deregulation of ER Functions
by: Lisanne E. Wisse, et al.
Published: (2017-12-01) -
Cortical Pathology in Vanishing White Matter
by: Jodie H. K. Man, et al.
Published: (2022-11-01) -
Regional vulnerability of brain white matter in vanishing white matter
by: Jodie H.K. Man, et al.
Published: (2023-06-01)